Live News EQUITY FLASH L impact Oct 28, 2026, 11:12 AM UTC Monte Rosa’s MRT-6160 Enters Phase 2 Trial Monte Rosa’s MRT-6160 has entered a Phase 2 trial in psoriatic arthritis. GLUE SquawkNews Desk